4//SEC Filing
Harding Thomas C. 4
Accession 0000899243-22-032655
CIK 0001466301other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:15 PM ET
Size
10.0 KB
Accession
0000899243-22-032655
Insider Transaction Report
Form 4
Harding Thomas C.
See Remarks
Transactions
- Sale
Common Stock
2022-10-03$1.29/sh−6$8→ 3,683 total(indirect: By Spouse) - Exercise/Conversion
Common Stock
2022-10-01+15→ 3,689 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Units
2022-10-01−15→ 109 total(indirect: By Spouse)→ Common Stock (15 underlying)
Holdings
- 17,816
Common Stock
Footnotes (3)
- [F1]Each Restricted Stock Unit represents the right to receive one share of Common Stock.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- [F3]On July 1, 2020, the reporting person's wife was granted 250 Restricted Stock Units. 25% of such Restricted Stock Units vested on July 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Documents
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeother
Related Parties
1- filerCIK 0001834833
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:15 PM ET
- Size
- 10.0 KB